DLD Video

health, medicine, technology, biotech, Laura Matz, Stefan Vilsmeier, David Kirkpatrick, DLD, talk

Speakers

Laura Matz

Merck Group
Laura Matz, Merck Group

Dr. Laura Matz is the Chief Science and Technology Officer for Merck, driving innovation and digitalization in Merck across the three business sectors of Life Sciences, Healthcare and Electronics. She has 20 years of experience in semiconductor manufacturing and a decade of experience running semiconductor materials businesses.

Profile Page

David Kirkpatrick

Techonomy Media
David Kirkpatrick, Techonomy

A journalist and media entrepreneur, David Kirkpatrick founded Techonomy Media, which he led for 12 years. He is now focusing on climate tech, climate action, and the crisis of global heating. Kirkpatrick’s bestselling book The Facebook Effect has been published in 32 languages.

Profile Page

Stefan Vilsmeier

Brainlab
Stefan Vilsmeier, Brainlab, AR, VR, health

Stefan Vilsmeier is the founder of Brainlab, a pioneer of digitizing medical workflows, from diagnosis to therapy. A self-taught computer programmer, Vilsmeier founded Brainlab in 1989 at the age of 17 after writing a bestselling book on 3D graphics. As CEO, he has overseen the company’s growth to more than 2400 employees in 25 locations worldwide.

Profile Page

More DLD Talks

Bitcoin expert Jörg Hermsdorf explains the importance of AI for cryptocurrencies at the DLD Munich 2024 conference. He’s seen speaking on stage in front of a colorful painting that shows early humans discover fire.

Bitcoin: The Lifeblood of Advanced AI

In his DLD24 presentation, crypto expert Jörg Hermsdorf explains that Bitcoin is a prime example of an adhocracy, a concept popularized in the 1970s, which has no traditional organizational structure yet can be…
Video Details
Hajo Schiewe (SandboxAQ) speaking at DLD Health x BAIOSPHERE conference, standing in front of bookshelves at Literaturhaus Munich, addressing the audience, on June 12, 2026. Photo: Dominik Gigler for DLD / Hubert Burda Media

Beyond Patterns: The Case for Physics-Grounded AI in Drug Discovery

Generative AI and large language models alone cannot solve the hardest problems in drug discovery, Hajo Schiewe, VP Strategic Business Development & Scientific Partnerships at SandboxAQ, argues in his DLD Health talk. These…
Video Details
magnifiercrosschevron-downchevron-rightmenu-circle
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram